PART I Overview We are the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry. Since our founding in 1996, we have been pioneers in the royalty market, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. We have assembled a portfolio of royalties which entitles us to payments based directly on...
Q2 FY2026 — expected 2026-09-15
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-11 | 2025-12-31 | 0001802768-26-000003 | EDGAR | 77K words |
| 2025-02-12 | 2024-12-31 | 0001802768-25-000010 | EDGAR | — |
| 2024-02-15 | 2023-12-31 | 0001802768-24-000012 | EDGAR | — |
| 2023-02-15 | 2022-12-31 | 0001802768-23-000007 | EDGAR | — |
| 2022-02-15 | 2021-12-31 | 0001802768-22-000011 | EDGAR | — |
| 2021-02-24 | 2020-12-31 | 0001802768-21-000006 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-05 | 2026-06-30 | 0001802768-26-000015 | EDGAR | — |
| 2025-11-05 | 2025-09-30 | 0001802768-25-000114 | EDGAR | 59K words |
| 2025-08-06 | 2025-06-30 | 0001802768-25-000095 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0001802768-25-000027 | EDGAR | — |
| 2024-11-06 | 2024-09-30 | 0001802768-24-000058 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001802768-24-000045 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0001802768-24-000021 | EDGAR | — |
| 2023-11-08 | 2023-09-30 | 0001802768-23-000029 | EDGAR | — |
| 2023-08-08 | 2023-06-30 | 0001802768-23-000023 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0001802768-23-000015 | EDGAR | — |
| 2022-11-08 | 2022-09-30 | 0001802768-22-000045 | EDGAR | — |
| 2022-08-04 | 2022-06-30 | 0001802768-22-000035 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-05 | 0001802768-26-000014 | EDGAR | — |
| 2026-02-11 | 0001802768-26-000002 | EDGAR | 7K words |
| 2025-12-22 | 0001193125-25-328759 | EDGAR | — |
| 2025-12-22 | 0001193125-25-328100 | EDGAR | — |
| 2025-11-05 | 0001802768-25-000113 | EDGAR | — |
| 2025-09-16 | 0001193125-25-204983 | EDGAR | — |
| 2025-08-13 | 0001193125-25-179892 | EDGAR | — |
| 2025-08-06 | 0001193125-25-173988 | EDGAR | — |
| 2025-07-17 | 0001193125-25-160293 | EDGAR | — |
| 2025-05-19 | 0000950103-25-006186 | EDGAR | — |
112 total filings indexed. 84 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001802768 |
| Ticker | RPRX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | X0 |
| Website | https://www.royaltypharma.com |
| Listed | 2020-06-16 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/RPRX (~200 tokens, structured JSON with cryptographic provenance)